Back to results
US 2021/0275462 A1Published application
Nanoparticulate prodrugs
AssigneesCentre National De La Recherche Scientifique, Universite Paris-Sud 11
InventorsElias FATTAL, Nicolas TSAPIS, Mathilde LORSCHEIDER, Romain CANIONI, Franceline REYNAUD
Life of this patent
Estimating the term…
Abstract
Disclosed is an anti-inflammatory drug formulation, especially a corticosteroid prodrug nanoparticle. In a first aspect, a nanoparticle includes a therapeutic agent and a surface coating material. Also disclosed are a process of manufacturing at least one nanoparticle, a pharmaceutical composition, and pharmaceutical kits.
Claims20
Nanoparticle comprising a glucocorticoid prodrug and a surface coating material wherein the nanoparticle size is ranging from 20 to 400 nm;
- wherein the glucocorticoid prodrug is a lipophilic long-chain ester of a glucocorticoid;
- wherein the glucocorticoid prodrug is in an amorphous state;
- and wherein the glucocorticoid prodrug loading rate is higher than 10% in weight to the weight of nanoparticle.
Dependencies are inferred from the claim text.